MBL2 and cancer: The impact of MBL serum levels on cancer risk might be directly linked to its ability to bind apoptotic or necrotic cells and facilitate macrophage uptake without activating the complement pathway; recent in vitro studies show that MBL may act independently of the complement cascade by facilitating the ingestion of apoptotic cells by human macrophages through macropinocytosis [8], [30].